- Home
- MNDO vs MIRA Comparison
MNDO vs MIRA Comparison
Compare MNDO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- MIRA
- Stock Information
- Founded
- MNDO 1995
- MIRA 2020
- Country
- MNDO Israel
- MIRA United States
- Employees
- MNDO N/A
- MIRA N/A
- Industry
- MNDO EDP Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- MIRA Health Care
- Exchange
- MNDO Nasdaq
- MIRA Nasdaq
- Market Cap
- MNDO 24.2M
- MIRA 26.1M
- IPO Year
- MNDO 2000
- MIRA 2023
- Fundamental
- Price
- MNDO $1.20
- MIRA $1.40
- Analyst Decision
- MNDO
- MIRA Strong Buy
- Analyst Count
- MNDO 0
- MIRA 1
- Target Price
- MNDO N/A
- MIRA $17.00
- AVG Volume (30 Days)
- MNDO 59.4K
- MIRA 196.3K
- Earning Date
- MNDO 08-11-2025
- MIRA 08-14-2025
- Dividend Yield
- MNDO 18.18%
- MIRA N/A
- EPS Growth
- MNDO N/A
- MIRA N/A
- EPS
- MNDO 0.15
- MIRA N/A
- Revenue
- MNDO $20,155,000.00
- MIRA N/A
- Revenue This Year
- MNDO N/A
- MIRA N/A
- Revenue Next Year
- MNDO N/A
- MIRA N/A
- P/E Ratio
- MNDO $8.00
- MIRA N/A
- Revenue Growth
- MNDO N/A
- MIRA N/A
- 52 Week Low
- MNDO $1.02
- MIRA $0.73
- 52 Week High
- MNDO $2.13
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- MNDO 43.61
- MIRA 45.09
- Support Level
- MNDO $1.10
- MIRA $1.35
- Resistance Level
- MNDO $1.20
- MIRA $1.42
- Average True Range (ATR)
- MNDO 0.06
- MIRA 0.06
- MACD
- MNDO 0.01
- MIRA -0.01
- Stochastic Oscillator
- MNDO 72.00
- MIRA 23.81
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.